Health Dictionary Find a Doctor

Neurocardiogenic syncope

For patient information on this page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Kashish Goel, M.D.

Overview

Syncope or loss of consciousness is one of the most common presenting symptoms to the ER (about 3%) and accounts for 1% of the hospital admissions. The most common type of syncope is neurocardiogenic syncope, especially in young adults and pediatric patients. It is also called “vasovagal syncope” and accounts for 50-60% of the unexplained syncope cases[1]. Neurocardiogenic syncope involves loss of the autonomic nervous system, and inability of the body to maintain blood pressure and heart rate. It can be provoked by fear, emotional stress, excruciating pain, prolonged standing or vigorous exercise. Some of the cases are associated with particular situations like urination, defecation, or coughing[2].

References

  1. Kapoor WN (2000). “Syncope”. N. Engl. J. Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter |month= ignored (help)
  2. Grubb BP (2005). “Clinical practice. Neurocardiogenic syncope”. N. Engl. J. Med. 352 (10): 1004–10. doi:10.1056/NEJMcp042601. PMID 15758011. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Neurocardiogenic syncope is defined as a syndrome in which triggering of a neural reflex results in a usually self-limited episode of systemic hypotension characterized by both bradycardia (asystole or relative bradycardia) and peripheral vasodilation.[1][2]

It is caused by an abnormal or exaggerated autonomic response to various stimuli, commonly standing and emotion.[3][4] The underlying mechanism for this exaggerate autonomic response remains unclear; however, the activation of cardiac C fibres has shown to play role which subsequently causes reflex-mediated changes in the vascular tone and heart rate.[5] On the contrary, failure of autonomic reflex response results in orthostatic hypotension.

The pathogenesis for syncope in patients with hypersensitive carotid sinus and neurocardiogenic syncope remain the same with the only difference being the receptor involved to stimulate the brainstem nucleus.

Pathophysiology

The underlying mechanism of exaggerated autonomic response to various stimuli in patients with neurocardiogenic stimuli remains unclear. However, the activation of cardiac C-fibres has been implicated in the pathogenesis of neurocardiogenic syncope.[6]

Regardless of the triggers, the mechanism of syncope is similar among various vasovagal syncope syndromes.

Multiple triggering stimuli activate the nucleus tractus solitarius of the brainstem via the cardiac C fibres, which then results in the simultaneous enhancement of the parasympathetic nervous system (vagal) tone and withdrawal of the sympathetic nervous system tone.[7][5][8]

This results in a spectrum of hemodynamic responses:

  • On one end of the spectrum is the cardioinhibitory response caused by an increased vagal tone that is characterized by bradycardia and consequent hypotension that is significant enough to result in loss of consciousness.

As a result of increased vagal tone and vasodilation, subsequent decrease in venous return and cardiac output is observed which is significant enough to cause syncope or loss of consciousness.[9][10]

Neurocardiogenic Syncope

Triggers such as pain, post-exercise stimulate the sympathetic nervous system causing an increase in the sympathetic tone (tachycardia and increased cardiac contractility) which then causes reflex-mediated activation of the cardiac C fibres and brainstem nucleus to counterbalance these effects and results in an increased vagal tone and bradycardia.

Hypersensitive Carotid Sinus

Triggers such as carotid massage, rapid head turning cause stimulation of the carotid sinus and cardiopulmonary receptors which subsequently activate the brainstem nucleus to follow the common pathway of increased vagal tone and bradycardia.

References

  1. Grubb BP (2005). “Neurocardiogenic syncope and related disorders of orthostatic intolerance”. Circulation. 111 (22): 2997–3006. doi:10.1161/CIRCULATIONAHA.104.482018. PMID 15939833. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  2. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, Maloney JD, Raviele A, Ross B, Sutton R, Wolk MJ, Wood DL (1996). “Tilt table testing for assessing syncope. American College of Cardiology”. Journal of the American College of Cardiology. 28 (1): 263–75. PMID 8752825. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  3. Krediet CT, van Dijk N, Linzer M, van Lieshout JJ, Wieling W (2002). “Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing”. Circulation. 106 (13): 1684–9. PMID 12270863. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  4. Lu CC, Diedrich A, Tung CS, Paranjape SY, Harris PA, Byrne DW, Jordan J, Robertson D (2003). “Water ingestion as prophylaxis against syncope”. Circulation. 108 (21): 2660–5. doi:10.1161/01.CIR.0000101966.24899.CB. PMID 14623807. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  5. 5.0 5.1 Kapoor WN (2000). “Syncope”. The New England Journal of Medicine. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  6. Fogoros RN. Practical cardiac diagnosis: electrophysiologic testing. 3 rd ed. Malden, MA: Blackwell Publishing, 1999
  7. Fogoros RN. Practical cardiac diagnosis: electrophysiologic testing. 3 rd ed. Malden, MA: Blackwell Publishing, 1999
  8. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W (2001). “Guidelines on management (diagnosis and treatment) of syncope”. European Heart Journal. 22 (15): 1256–306. doi:10.1053/euhj.2001.2739. PMID 11465961. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  9. White CM, Tsikouris JP (2000). “A review of pathophysiology and therapy of patients with vasovagal syncope”. Pharmacotherapy. 20 (2): 158–65. PMID 10678294. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  10. Zaqqa M, Massumi A. Neurally mediated syncope. Tex Heart Institute J 2000;27: 268-72.

Template:WH Template:WS

Epidemiology & Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neurocardiogenic syncope is the most common cause of syncope in children and adults and accounts for approximately 10-40% of all syncopal episodes.

Incidence

The prevalence is 22% in the general population. Approximately 50%-66% of syncope cases are classified as due to vasovagal syncope.

References


Template:WikiDoc Sources

Risk Factors

Young adults and children are at the highest risk for experiencing Neurocardiogenic syncope but, they commonly grow out of this condition as they reach adulthood. It also tends to occur in persons who have a family history of fainting spells. It is thought to affect persons who have a genetic predisposition towards poor resistance in the blood vessels of the lower extremities, causing blood to pool away from the brain in response to certain situations.

Causes

Neurocardiogenic syncope occurs when the part of the nervous system that regulates heart rate and blood pressure temporarily malfunctions. Usually in response to some sort of trigger such as fear or the sight of blood, the heart rate slows down, and the blood vessels in the legs dilate. This causes blood to pool in the lower region of the body, and therefore a lack of blood and oxygen to the brain which causes fainting. This is similar to what happens when one feels faint after suddenly standing up. When a person faints, gravity causes blood flow to to the brain to be restored and the person gains consciousness. Neurocardiogenic syncope is a symptom of the body, rather than a disease. Possible triggers causing neurocardiogenic syncope are as follows;

Natural History, Prognosis & Complication

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Vasovagal syncope usually has an easily identified triggering event such as emotional stress, trauma, pain, the sight of blood, or prolonged standing. Syncope recurs in few patients, while others just experience a single episode. The prognosis is usually good, although prolonged hypotension may cause severe damage. Mortality associated with syncope is largely due to severity of the underlying disease rather than syncope per se.

Natural History

The natural history of neurocardiogenic syncope is extremely variable; some patients experience single episode while others have recurrent episodes. [1]

In an european study, 465 patients were evaluated for an early (1 month) and late (2 years) death rate and syncopal relapses of patients referred for syncope to 11 general hospitals emergency departments. The following results were found:[2]

  • The death rate was higher (17% of all deaths) in the first month of observation
  • Reoccurrence of the syncopal episode was low overall in both the short and the long term (0.3% and 0.8% in the first month and in the second year, respectively).
  • Mortality was higher in patients having previous cardiovascular disease or in those displaying ECG abnormalities. Both of these two factors represent the main predictors of short or long-term mortality on multivariate analysis

Prognosis

Vasovagal syncope appears to have a benign prognosis.[3] Patients recover completely within minutes to hours and have excellent prognosis as far as survival is concerned.[4] If syncope is symptomatic of an underlying condition, then the prognosis will reflect the course of the disorder and not the syncope itself.[5][6] Such patient’s should be stratified with respect to the risk of a cardiovascular event and/or sudden cardiac death and further evaluation should be made. [7]

Supportive Trial Data

  • A study of 334 patients with a mean follow up of 30.4 ± 21 months, showed good survival of patients with neurocardiogenic syncope, presenting after an abnormal head-up tilt (HUT) test. [8] The study showed that there were no cardiac deaths in during 30.4 ± 21 months. However, 101 patients (30.2%) had recurrences (1 recurrence, n = 64; > or =2, n = 37), which were not influenced by the type of response during HUT or by age.

Prognostic indicators

  • The duration of loss of consciousness during the syncope.[9]
  • Co-morbid disease or Underlying cardiac illness (Hemodynaically important aortic stenosis) [10]
  • Increased age.

Predictors for recurrences of vasovagal syncope

The presence of following conditions increase the risk of vasovagal syncope: [11]

  • The number of previous syncope and presyncope.
  • Female gender.
  • History of bronchial asthma.

A group of authors have designed a simple clinical risk score to predict the risk of recurrence of vasovagal syncope.[11]

Complication

The main danger of fainting fits or vasovagal syncope is the risk of injury by falling while unconscious. American Heart Association (AHA), North American Society of Pacing and Electrophysiology (NASPE, now Heart Rhythm Society, HRS) and European Society of Cardiology have published recommendations for driving in patients with syncope.[12][13][14]

The quality of life (QoL) of patients suffering from neurocardiogenic shock is similar to those with NYHA class II-III heart failure.[15]

Risk of death and life-threatening events

Major risk factors for sudden cardiac death and overall mortality in patients are structural heart diseases[16][17] and primary electrical disturbances.[18]

Recurrence of syncope and risk of physical injury

  • Morbidity is particulary high in the elderly due to the following contributing factors:[19][20]
    • Loss of confidence.
    • Depressive illness.
    • Fear of falling, to fractures and subsequent institutionalization.
  • Mortality in syncope patients depends on the underlying cause:[21]
    • Cardiac causes (arrhythmias or cardiovascular disease) have a 20-30% mortality.
    • Non-cardiac causes have 5-10% mortality.

However, a major drawback in determining the true mortality rate is that most individuals with transient loss of consciousness do not seek medical advice.

Reference

  1. Alboni P, Brignole M, Degli Uberti EC (2007). “Is vasovagal syncope a disease?”. Europace. 9 (2): 83–7. doi:10.1093/europace/eul179. PMID 17272328.
  2. Ungar A, Del Rosso A, Giada F, Bartoletti A, Furlan R, Quartieri F; et al. (2010). “Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study”. Eur Heart J. 31 (16): 2021–6. doi:10.1093/eurheartj/ehq017. PMID 20167743.
  3. Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ; et al. (2002). “Incidence and prognosis of syncope”. N Engl J Med. 347 (12): 878–85. doi:10.1056/NEJMoa012407. PMID 12239256.
  4. Ruiz GA, Peralta A, Gonzalez-Zuelgaray J, Duce E (1995). “Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment”. Am Heart J. 130 (2): 345–50. PMID 7631619.
  5. Eagle KA, Black HR, Cook EF, Goldman L (1985). “Evaluation of prognostic classifications for patients with syncope”. Am. J. Med. 79 (4): 455–60. PMID 4050832. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  6. Morady F, Shen E, Schwartz A, Hess D, Bhandari A, Sung RJ, Scheinman MM (1983). “Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing”. J. Am. Coll. Cardiol. 2 (6): 1053–9. PMID 6630777. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  7. Veltmann C, Borggrefe M, Wolpert C, Schimpf R (2010). “Evaluation and management of syncope”. Minerva Cardioangiol. 58 (6): 701–15. PMID 21135810.
  8. Barón-Esquivias G, Errázquin F, Pedrote A, Cayuela A, Gómez S, Aguilera A, Campos A, Fernández M, Valle JI, Redondo M, Fernández JM, Martínez A, Burgos J, Martínez-Rubio A (2004). “Long-term outcome of patients with vasovagal syncope”. Am. Heart J. 147 (5): 883–9. doi:10.1016/j.ahj.2003.11.022. PMID 15131546. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  9. Zyśko D, Gajek J, Kozluk E, Agrawal AK, Smereka J, Checiński I (2010). “The clinical relevance of the duration of loss of consciousness provoked by tilt testing”. Acta Cardiol. 65 (2): 203–9. PMID 20458828. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  10. Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS (1983). “A prospective evaluation and follow-up of patients with syncope”. N. Engl. J. Med. 309 (4): 197–204. doi:10.1056/NEJM198307283090401. PMID 6866032. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  11. 11.0 11.1 Aydin MA, Maas R, Mortensen K, Steinig T, Klemm H, Risius T, Meinertz T, Willems S, Morillo CA, Ventura R (2009). “Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine”. J. Cardiovasc. Electrophysiol. 20 (4): 416–21. doi:10.1111/j.1540-8167.2008.01352.x. PMID 19017338. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  12. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, Garson A, Harvey JC, Kidwell GA, Klein GJ, Levine PA, Marchlinski FE, Prystowsky EN, Wilkoff BL (1996). “Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”. Circulation. 94 (5): 1147–66. PMID 8790068. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  13. Epstein AE, Baessler CA, Curtis AB, Estes NA, Gersh BJ, Grubb B, Mitchell LB (2007). “Addendum to “Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”: public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society”. Circulation. 115 (9): 1170–6. doi:10.1161/CIRCULATIONAHA.106.180203. PMID 17287391. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  14. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W (2009). “Guidelines for the diagnosis and management of syncope (version 2009)”. Eur. Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  15. Barón-Esquivias G, Cayuela A, Gómez S, Aguilera A, Campos A, Fernández M, Cabezón S, Morán JE, Valle JI, Martínez A, Pedrote A, Errázquin F, Burgos J (2003). “[Quality of life in patients with vasovagal syncope. Clinical parameters influence]”. Med Clin (Barc) (in Spanish; Castilian). 121 (7): 245–9. PMID 12975035. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  16. Martin TP, Hanusa BH, Kapoor WN (1997). “Risk stratification of patients with syncope”. Ann Emerg Med. 29 (4): 459–66. PMID 9095005. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  17. Olshansky B, Poole JE, Johnson G, Anderson J, Hellkamp AS, Packer D, Mark DB, Lee KL, Bardy GH (2008). “Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study”. J. Am. Coll. Cardiol. 51 (13): 1277–82. doi:10.1016/j.jacc.2007.11.065. PMID 18371559. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  18. Wehrens XH, Vos MA, Doevendans PA, Wellens HJ (2002). “Novel insights in the congenital long QT syndrome”. Ann. Intern. Med. 137 (12): 981–92. PMID 12484714. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  19. Ungar A, Mussi C, Del Rosso A, Noro G, Abete P, Ghirelli L, Cellai T, Landi A, Salvioli G, Rengo F, Marchionni N, Masotti G (2006). “Diagnosis and characteristics of syncope in older patients referred to geriatric departments”. J Am Geriatr Soc. 54 (10): 1531–6. doi:10.1111/j.1532-5415.2006.00891.x. PMID 17038070. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  20. Costantino G, Perego F, Dipaola F, Borella M, Galli A, Cantoni G, Dell’Orto S, Dassi S, Filardo N, Duca PG, Montano N, Furlan R (2008). “Short- and long-term prognosis of syncope, risk factors, and role of hospital admission: results from the STePS (Short-Term Prognosis of Syncope) study”. J. Am. Coll. Cardiol. 51 (3): 276–83. doi:10.1016/j.jacc.2007.08.059. PMID 18206736. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  21. White CM, Tsikouris JP (2000). “A review of pathophysiology and therapy of patients with vasovagal syncope”. Pharmacotherapy. 20 (2): 158–65. PMID 10678294.


Template:WikiDoc Sources

Differentiating Neurocardiogenic Syncope From Other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neurocardiogenic syncope must be distinguished from situational syncope (cough syncope, defecation syncope, micturation syncope, neurally mediated syncope and carotid sinus hypersensitivity). Some patients will have what is called an “atypical” syncope, which is non-neurocardiogenic and without any identifiable triggers.

Situational Syncope

The syncope comes on after cough, defecation, or micturation

Neurally Mediated Syncope

This form of syncope occurs in the context of severe throat or facial pain as occurs in glossopharyngeal neuralgia or trigeminal neuralgia.

Neurocardiogenic Syncope

Syncope following exposure to a noxious stiumulus, fear, or pain is consistent with neurocardiogenic syncope.

Carotid Sinus Syncope

Carotid sinus syncope may occur with rotation or turning of the head or pressure on the carotid sinus (for example, carotid massage, shaving, tight collars or neck wear, or tumor compression).

Cardiac Syncope

Occurs due to an arrythmia, and is of abrupt onset and short duration, without any recovery phase.

References


Template:WikiDoc Sources

Diagnosis

Diagnosis

History & Symptoms | Physical Examination | Electrocardiogram | Chest X-Ray | Tilt table test | Echocardiography | Cardiac Catheterization

Treatment

Treatment

Related Chapters


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH